DK1137442T3 - Biologisk aktive konjugater havende en detekterbar rapportermoietet og fremgangsmåde til identificering af nævnte derivat - Google Patents

Biologisk aktive konjugater havende en detekterbar rapportermoietet og fremgangsmåde til identificering af nævnte derivat

Info

Publication number
DK1137442T3
DK1137442T3 DK99973261T DK99973261T DK1137442T3 DK 1137442 T3 DK1137442 T3 DK 1137442T3 DK 99973261 T DK99973261 T DK 99973261T DK 99973261 T DK99973261 T DK 99973261T DK 1137442 T3 DK1137442 T3 DK 1137442T3
Authority
DK
Denmark
Prior art keywords
identifying
derivative
biologically active
active conjugates
detectable reporting
Prior art date
Application number
DK99973261T
Other languages
Danish (da)
English (en)
Inventor
Oddone Schiavon
Francesco Veronese
Paolo Caliceti
Piero Orsolini
Original Assignee
Debio Rech Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debio Rech Pharma Sa filed Critical Debio Rech Pharma Sa
Application granted granted Critical
Publication of DK1137442T3 publication Critical patent/DK1137442T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/65Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DK99973261T 1998-12-08 1999-12-08 Biologisk aktive konjugater havende en detekterbar rapportermoietet og fremgangsmåde til identificering af nævnte derivat DK1137442T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98123307A EP1008355A1 (de) 1998-12-08 1998-12-08 Verfahren zur Identifizierung der Bindungsstellen eines Polymeren an Makromolekülen mit Markierungsbindung von Aminosäuren
PCT/IB1999/001957 WO2000033881A1 (en) 1998-12-08 1999-12-08 Biologically active conjugates having a detectable reporter moiety and method of identification of said derivative
EP99973261A EP1137442B1 (de) 1998-12-08 1999-12-08 Biologisch wirksame konjugate mit einem reporterrest und verfahren zu dessen nachweis

Publications (1)

Publication Number Publication Date
DK1137442T3 true DK1137442T3 (da) 2005-03-14

Family

ID=8233105

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99973261T DK1137442T3 (da) 1998-12-08 1999-12-08 Biologisk aktive konjugater havende en detekterbar rapportermoietet og fremgangsmåde til identificering af nævnte derivat

Country Status (10)

Country Link
US (1) US6790942B1 (de)
EP (2) EP1008355A1 (de)
JP (1) JP2002531529A (de)
AT (1) ATE283068T1 (de)
AU (1) AU757665B2 (de)
CA (1) CA2354868A1 (de)
DE (1) DE69922245T2 (de)
DK (1) DK1137442T3 (de)
ES (1) ES2233107T3 (de)
WO (1) WO2000033881A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100396983B1 (ko) * 2000-07-29 2003-09-02 이강춘 고반응성의 가지 달린 고분자 유도체 및 고분자와 단백질또는 펩타이드의 접합체
KR100508358B1 (ko) 2002-03-20 2005-08-17 주식회사 바이오폴리메드 생체적합성 고분자가 시스테인 잔기에 화학양론적으로 결합된 g-csf의 제조 방법
EA010099B1 (ru) 2003-05-12 2008-06-30 Афимакс, Инк. Пептиды, которые связываются с рецептором к эритропоэтину, и способы их применения
EP2204193A3 (de) 2003-05-12 2010-08-18 Affymax, Inc. Spacer-Bestandteile für Poly(ethylenglykol)-modifizierte Verbindungen auf Peptidbasis
CA2525568C (en) 2003-05-12 2017-07-25 Affymax, Inc. Novel peptides that bind to the erythropoietin receptor
US7550433B2 (en) 2005-06-03 2009-06-23 Affymax, Inc. Erythropoietin receptor peptide formulations and uses
JP2010520855A (ja) 2007-01-31 2010-06-17 アフィーマックス・インコーポレイテッド 修飾基をポリペプチドおよびその他の高分子に結合するための窒素ベースのリンカー
US8609621B2 (en) 2010-11-15 2013-12-17 E I Du Pont De Nemours And Company Acid-cleavable linkers exhibiting altered rates of acid hydrolysis
CN105324116B (zh) * 2013-04-26 2019-03-29 新加坡科技研究局 调适具有聚脯氨酸支架的生物聚合物的多价相互作用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1219454B (it) * 1988-02-17 1990-05-18 Serono Cesare Ist Ricerca Metodo di rottura alla metionina di polipeptidi contenenti pontidisolfuro
US5286637A (en) * 1989-08-07 1994-02-15 Debiopharm, S.A. Biologically active drug polymer derivatives and method for preparing same
DK0437563T3 (da) * 1989-08-07 1995-05-29 Debio Rech Pharma Sa Bioligiske aktive lægemiddelpolymerderivater
WO1992020362A1 (en) * 1991-05-14 1992-11-26 Shashoua Victor E Nerve growth peptides and uses therefor
DE59205565D1 (de) * 1991-10-07 1996-04-11 Hoechst Ag Carbonsäureester-Schutzgruppen, ein Verfahren zu ihrer Herstellung, ihre Kopplung an eine funktionelle Gruppe sowie ihre Verwendung

Also Published As

Publication number Publication date
ES2233107T3 (es) 2005-06-01
ATE283068T1 (de) 2004-12-15
WO2000033881A1 (en) 2000-06-15
US6790942B1 (en) 2004-09-14
CA2354868A1 (en) 2000-06-15
AU757665B2 (en) 2003-02-27
EP1008355A1 (de) 2000-06-14
AU1402800A (en) 2000-06-26
EP1137442B1 (de) 2004-11-24
JP2002531529A (ja) 2002-09-24
EP1137442A1 (de) 2001-10-04
DE69922245D1 (de) 2004-12-30
DE69922245T2 (de) 2005-11-24

Similar Documents

Publication Publication Date Title
DK1053355T3 (da) PNA- og DNA-konjugater og metoder til fremstilling heraf
ATE360033T1 (de) Ortsspezifische proteinmodifizierung durch mutagenese
ATE302286T1 (de) Sequenzierungsverfahren mit signalverstärkern
CY1117239T1 (el) Συνδυαστικες συνθεσεις διπλοκοκκου του neisser
BR9812267A (pt) Derivados de hormonio de crescimento eproteìnas relacionadas
DK0787205T3 (da) Fremgangsmåde til amplifikation af nukleinsyrer på en fast fase og reagenskit dertil
DK1137442T3 (da) Biologisk aktive konjugater havende en detekterbar rapportermoietet og fremgangsmåde til identificering af nævnte derivat
DK0943097T3 (da) Fremgangsmåde til at påvise IgE
DK1124568T3 (da) Polyspecifikke bindingsmolekyler og anvendelser deraf
ATE448077T1 (de) Nanokristalle
ATE555202T1 (de) Verfahren zur lieferung von rna-interferenz und verwendungen damit
ATE336578T1 (de) Nukleinsäurebindungsproteine
DE60118527D1 (de) Sensible und multiplexe diagnostische tests zur proteinanalyse
ATE269416T1 (de) Verwendung von vereinigten sonden zur genetischen analyse
DK592489D0 (da) Glycosphingolipider, deres fremstillng og anvendelse
NO20023811L (no) Sammensetninger og fremgangsmåter for overflatepreging
DE60044420D1 (de) Enzym-Protein-Komplex
DE60220136D1 (de) Universeller träger zum zielrichten von molekülen zu rezeptor gb3 - exprimierenden zellen
ATE389881T1 (de) Detektion von kleinen molekülen mit piezo- elektrischem sensor
WO2006079099A3 (en) Method of conjugating aminothiol containing molecules to a polymer
ATE319735T1 (de) Aufreinigung von substanzen aus einer biologischen probe
ATE233405T1 (de) Verfahren zur detektierung eines biologischen materials, eingangphase, detektionsphase und diese enthaltende reagenz
DE60315343D1 (de) Neuartige verwendungen von durch ble-gene kodierten proteinen und antibiotika aus der bleomycin-familie
DE59902301D1 (de) Verfahren zur modifikation und identifikation funktioneller stellen in proteinen
NO20011744L (no) Ioniske molekyl¶re konjugater av N-acylerte derivater av poly(2-amino-2-deoksy-d-glukose) og polypeptider